Neo Ivy Capital Management - IMMUNOMEDICS INC ownership

Quarter-by-quarter ownership
Neo Ivy Capital Management ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2021$15,0000.0%4300.0%0.02%
+183.3%
Q2 2020$15,000
+36.4%
430
-46.8%
0.01%
-66.7%
Q1 2020$11,000
-98.3%
809
-97.3%
0.02%
-97.6%
Q4 2019$643,000
+89.7%
30,388
+14.9%
0.74%
+235.1%
Q3 2019$339,000
-26.3%
26,449
+10.4%
0.22%
-14.9%
Q1 2019$460,00023,9500.26%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders